Tevogen Inc.
TVGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q2 2026, worth $607.7K in total; no superinvestor holds it.
Other share classesTVGNW
Holders of 5% or more of TVGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tevogen Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Saadi Ryan H. | 13D/A | 74.40%11.7M shares | – | Sep 16, 20261 filing | Sep 16, 2026 | SEC |
| Saadi Ryan H. | 13D/A | 59.70%3.71M shares | −2.30 ppfrom 62.00% | Feb 22, 20244 filings | Jul 14, 2026 | SEC |
| Desai Kirti | 13D/A | 6.30%993.0K shares | – | Feb 22, 20242 filings | Sep 16, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
28 Schedule 13D and 13G filings on Tevogen Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 20268:07 PM ET | Saadi Ryan H. | 13D/A | 74.40%11.7M shares | – | Sep 14, 2026 | SEC |
| Sep 16, 20268:04 PM ET | Desai Kirti | 13D/A | 6.30%993.0K shares | – | Sep 14, 2026 | SEC |
| Jul 14, 20269:56 PM ET | Saadi Ryan H. | 13D/A | 59.70%3.71M shares | −2.30 ppfrom 62.00% | Jul 10, 2026 | SEC |
| Dec 16, 20258:47 PM ET | Saadi Ryan H. | 13D/A | 62.00%124.5M shares | −2.50 ppfrom 64.50% | Dec 11, 2025 | SEC |
| Jul 25, 20257:48 PM ET | Saadi Ryan H. | 13D/A | 64.50%125.0M shares | – | Jun 27, 2025 | SEC |
| Mar 4, 2024 | Patel Manmohan | 13GOld format | – | New | – | SEC |
| Feb 22, 2024 | Desai Kirti | 13DOld format | – | New | – | SEC |
| Feb 22, 2024 | Saadi Ryan H. | 13DOld format | – | New | – | SEC |
| Feb 14, 2024 | Citadel Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Calamos Investment Trust | 13GOld format | – | – | – | SEC |
| Feb 14, 2024 | Glazer Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 12, 2024 | Polar Asset Management Partners Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2024 | Saba Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 22, 2024 | Harraden Circle Investments, LLC | 13GOld format | – | New | – | SEC |
| Jul 27, 2023 | Citadel Advisors LLC | 13GOld format | – | New | – | SEC |
| Jul 20, 2023 | Corbin Capital Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jul 7, 2023 | SSVK Associates, LLC | 13DOld format | – | New | – | SEC |
| Jun 8, 2023 | Semper Paratus Sponsor LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Saba Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Polar Asset Management Partners Inc. | 13GOld format | – | New | – | SEC |
| Feb 13, 2023 | Semper Paratus Sponsor LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Saba Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Corbin Capital Partners, L.P. | 13GOld format | – | New | – | SEC |
| Feb 8, 20222:42 PM ET | Calamos Investment Trust | 13GOld format | – | New | – | SEC |
| Nov 15, 2021 | Semper Paratus Sponsor LLC | 13DOld format | – | New | – | SEC |
| Nov 12, 2021 | Saba Capital Management, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Tevogen Inc. shares.
No Form 144 notices for Tevogen Inc. are on file.